Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04356391 · ClinicalTrials.gov registry record · NA
Pinhole Surgical Technique Compared to Connective Tissue Graft in Treatment of Gingival Recession
A NA study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT04356391: Completed NA study, sponsored by State University of New York at Buffalo.
NCT04356391 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04356391, a NA study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study compares the efficacy of root coverage achieved by the Pinhole Surgical Technique (PST) technique and the Connective Tissue Graft (CTG) technique in the treatment of Miller class I and II gingival recession defects. All patients will receive PST in one quadrant and CTG in another quadrant. The hypothesis being tested is: Pinhole Surgical Technique outcomes are not inferior to those of the Connective Tissue Graft surgical technique.
Primary Outcome
Complete root coverage (CRC): The number of sites that resulted in 100% root coverage.
Interventions
- PROCEDURE Connective Tissue Graft Technique
- PROCEDURE Pinhole Surgical Technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2018-01-24 |
| Est. Completion | 2023-04-26 |
| Phase | NA |
What the finished NCT04356391 record still lists
NCT04356391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Connective Tissue Graft Technique is the first listed.
NCT04356391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04356391 about?
NCT04356391 is a clinical study titled "Pinhole Surgical Technique Compared to Connective Tissue Graft in Treatment of Gingival Recession". This study compares the efficacy of root coverage achieved by the Pinhole Surgical Technique (PST) technique and the Connective Tissue Graft (CTG) technique in the treatment of Miller class I and II gingival recession defects. All patients will receive PST in one quadrant and CTG in another quadrant...
What is the current status of trial NCT04356391?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2018-01-24. Estimated completion is 2023-04-26.
What interventions are being tested in trial NCT04356391?
The interventions under investigation include: Connective Tissue Graft Technique (PROCEDURE), Pinhole Surgical Technique (PROCEDURE).
Who is sponsoring clinical trial NCT04356391?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04356391's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI